A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
This is a safety and efficacy study of LiRIS® in females with interstitial cystitis/bladder pain syndrome.
Inclusion Criteria:
Exclusion Criteria:
Fort Wayne, Indiana 46825, United States
St Louis, Missouri 63117, United States
Voorhees Township, New Jersey 08043, United States
Lake Success, New York 11042, United States